Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-25-005923
Filing Date
2025-08-14
Accepted
2025-08-14 16:54:18
Documents
78
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vnrx_10q.htm   iXBRL 10-Q 1710193
2 CERTIFICATION vnrx_ex311.htm EX-31.1 12102
3 CERTIFICATION vnrx_ex312.htm EX-31.2 13039
4 CERTIFICATION vnrx_ex321.htm EX-32.1 6656
  Complete submission text file 0001477932-25-005923.txt   8414332

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20250630.xsd EX-101.SCH 91360
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20250630_lab.xml EX-101.LAB 454132
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20250630_cal.xml EX-101.CAL 59899
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20250630_pre.xml EX-101.PRE 432674
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20250630_def.xml EX-101.DEF 313576
81 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 1603439
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 251220522
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)